Aerovate Therapeutics, Inc. (AVTE) Ownership

$2.51

south_east
-$0.05 (-1.76%)
Day's range
$2.5
Day's range
$2.53

Aerovate Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 11/14/2024 9.19 M $19.21 M   0.00% 31.85%
SOFINNOVA INVESTMENTS, INC. 11/13/2024 3.76 M $7.86 B   0.00% 13.02%
TCG CROSSOVER MANAGEMENT, LLC 11/14/2024 2.24 M $4.68 M   0.00% 7.76%
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 11/13/2024 1.80 M $3.76 M   0.00% 6.23%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11/14/2024 1.41 M $2.95 M   0.00% 4.89%
VANGUARD GROUP INC 11/13/2024 1.15 M $2.41 M   4.21% 3.99%
BLACKROCK FUNDING, INC. /DE 11/13/2024 953,676 $1.99 M   100.00% 3.30%
BAKER BROS. ADVISORS LP 11/14/2024 628,939 $1.31 M   0.00% 2.18%
AFFINITY ASSET ADVISORS, LLC 11/13/2024 600,000 $1.25 M   200.00% 2.08%
EVERSEPT PARTNERS, LP 11/14/2024 485,141 $1.01 M   100.00% 1.68%
OCTAGON CAPITAL ADVISORS LP 11/14/2024 465,440 $972,770   0.00% 1.61%
OPALEYE MANAGEMENT INC. 11/14/2024 440,000 $919,600   0.00% 1.52%
GSA CAPITAL PARTNERS LLP 11/05/2024 413,795 $865,000   226.77% 1.43%
IKARIAN CAPITAL, LLC 11/14/2024 367,965 $769,046   0.00% 1.27%
STATE STREET CORP 11/14/2024 367,468 $768,008   7.70% 1.27%
ACADIAN ASSET MANAGEMENT LLC 11/12/2024 359,376 $750,000   100.00% 1.25%
MORGAN STANLEY 11/14/2024 333,968 $697,994   545.09% 1.16%
TWO SIGMA INVESTMENTS, LP 11/14/2024 313,114 $654,408   12.30% 1.08%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 291,887 $610,134   -7.97% 1.01%
BANK OF AMERICA CORP /DE/ 11/14/2024 261,031 $545,555   1,262.37% 0.90%
MILLENNIUM MANAGEMENT LLC 11/14/2024 196,644 $410,986   -69.37% 0.68%
GOLDMAN SACHS GROUP INC 11/14/2024 161,011 $336,513   77.04% 0.56%
ADAR1 CAPITAL MANAGEMENT, LLC 11/14/2024 113,075 $236,327   -54.21% 0.39%
TWO SIGMA ADVISERS, LP 11/14/2024 110,900 $231,781   58.88% 0.38%
VERITION FUND MANAGEMENT LLC 11/14/2024 99,815 $208,613   -59.91% 0.35%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2024 97,842 $204,490   -11.33% 0.34%
FMR LLC 11/13/2024 82,919 $173,301   54,095.42% 0.29%
ALLIANCEBERNSTEIN L.P. 11/14/2024 69,910 $146,112   0.00% 0.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 67,200 $140,448   14.68% 0.23%
VOYA INVESTMENT MANAGEMENT LLC 11/14/2024 65,659 $137,227   100.00% 0.23%
CITADEL ADVISORS LLC 11/14/2024 48,500 $101,365   336.94% 0.17%
NAN FUNG GROUP HOLDINGS LTD 11/13/2024 47,936 $100,186   0.00% 0.17%
AQR CAPITAL MANAGEMENT LLC 11/14/2024 45,343 $94,766   100.00% 0.16%
BANK OF NEW YORK MELLON CORP 11/12/2024 41,466 $86,664   -11.75% 0.14%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 40,047 $83,698   0.00% 0.14%
BANK OF MONTREAL /CAN/ 11/13/2024 31,644 $65,187   100.00% 0.11%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 29,351 $61,344   -43.65% 0.10%
STATE OF WISCONSIN INVESTMENT BOARD 11/14/2024 29,009 $60,629   16.50% 0.10%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 25,700 $53,713   -38.95% 0.09%
EXODUSPOINT CAPITAL MANAGEMENT, LP 11/12/2024 21,105 $44,000   -2.84% 0.07%
BARCLAYS PLC 11/19/2024 18,972 $39,000   310.83% 0.07%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 17,900 $37,411   100.00% 0.06%
JANE STREET GROUP, LLC 11/15/2024 17,805 $37,213   -83.85% 0.06%
RHUMBLINE ADVISERS 11/12/2024 13,266 $27,719   -12.05% 0.05%
SG AMERICAS SECURITIES, LLC 10/03/2024 11,018 $23,000   -93.86% 0.04%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 10,579 $22,097   -9.02% 0.04%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2024 10,235 $21,391   100.00% 0.04%
CORSAIR CAPITAL MANAGEMENT, L.P. 11/13/2024 10,100 $21,109   -49.75% 0.04%
GROUP ONE TRADING, L.P. 11/14/2024 9,917 $20,727   253.42% 0.03%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2024 7,438 $15,545   52.39% 0.03%

Aerovate Therapeutics, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of AVTE shares?

During the previous two years, 89 institutional investors and hedge funds held shares of Aerovate Therapeutics, Inc.. The most heavily invested institutionals were:

SG Americas Securities, LLC: 0

RA CAPITAL MANAGEMENT, L.P.: 9.19 M

Sofinnova Investments, Inc.: 3.76 M

TCG Crossover Management, LLC: 2.24 M

Atlas Venture Life Science Advisors, LLC: 1.8 M

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 1.41 M

What percentage of Aerovate Therapeutics, Inc. stock is owned by institutional investors?

95.78% of Aerovate Therapeutics, Inc. stock is owned by institutional investors.

How much institutional buying is happening at AVTE ?

Institutional investors have bought a total of 28.88 M shares in the last 24 months. This purchase volume represents approximately $72.49 M in transactions.